Wegovy, Mounjaro, Vyleesi, Zadaxin in the relevant jurisdictions) has been through EMA or national-authority review, carries an authorised indication, and is dispensed by a pharmacy against a script
For patients who do not adequately achieve good glycaemic control or show contraindication to the above-mentioned drugs, insulin treatment should be suggested, first as long-acting insulin and after as a basal-bolus scheme ( Figure 2 )
Safe GLP-1 therapy generally requires: Baseline metabolic laboratory testing Medication review Screening for thyroid and pancreatic history Ongoing clinical follow-up Lowering the dose does not eliminate contraindications
This reinforces the importance of viewing semaglutide as part of a broader health strategy rather than a quick fix
Energy levels typically stabilize once your dose reaches a therapeutic level, and many users find they feel more energized overall once weight loss begins and cardiovascular stress from excess weight decreases